169 related articles for article (PubMed ID: 37002875)
1. Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
Vuyyuru SK; Nguyen TM; Hogan M; Raine T; Noor NM; Narula N; Verstockt B; Feagan BG; Singh S; Ma C; Jairath V
Inflamm Bowel Dis; 2024 Apr; 30(4):651-659. PubMed ID: 37002875
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials.
Almradi A; Sedano R; Hogan M; Zou GY; MacDonald JK; Parker CE; Hanzel J; Crowley E; Singh S; D'Haens G; Sandborn WJ; Feagan BG; Ma C; Jairath V
J Crohns Colitis; 2022 Jun; 16(5):717-736. PubMed ID: 34758084
[TBL] [Abstract][Full Text] [Related]
3. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.
Jairath V; Zou GY; Parker CE; MacDonald JK; AlAmeel T; Al Beshir M; Almadi MA; Al-Taweel T; Atkinson NS; Biswas S; Chapman T; Dulai PS; Glaire MA; Hoekman DR; Koutsoumpas A; Minas E; Mosli MH; Samaan M; Khanna R; Travis S; D'Haens G; Sandborn WJ; Feagan BG
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011572. PubMed ID: 28886205
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
5. Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.
Sharma T; Ma C; Sedano R; Hanzel J; McDonald C; Hogan M; Kochhar GS; Narula N; Peyrin-Biroulet L; Danese S; MacDonald JK; Jairath V
J Crohns Colitis; 2023 Apr; 17(4):644-658. PubMed ID: 36271904
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab for maintenance of remission in Crohn's disease.
Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
[TBL] [Abstract][Full Text] [Related]
7. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
8. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
9. Low dose naltrexone for induction of remission in Crohn's disease.
Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab for induction of remission in Crohn's disease.
Abbass M; Cepek J; Parker CE; Nguyen TM; MacDonald JK; Feagan BG; Khanna R; Jairath V
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742665
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics for induction and maintenance of remission in Crohn's disease.
Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
[TBL] [Abstract][Full Text] [Related]
12. Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.
Roseira J; Santiago M; Estevinho MM; Moreira P; Alves C; Danese S; Peyrin-Biroulet L; Dignass A; Feakins R; Magro F
Inflamm Bowel Dis; 2023 Aug; 29(8):1231-1243. PubMed ID: 36250778
[TBL] [Abstract][Full Text] [Related]
13. Response to Placebo, Measured by Endoscopic Evaluation of Crohn's Disease Activity, in a Pooled Analysis of Data From 5 Randomized Controlled Induction Trials.
Duijvestein M; Jeyarajah J; Guizzetti L; Zou G; Parker CE; van Viegen T; VandeCasteele N; Khanna R; Van Der Aa A; Sandborn WJ; Feagan BG; D'Haens GR; Jairath V
Clin Gastroenterol Hepatol; 2020 May; 18(5):1121-1132.e2. PubMed ID: 31442599
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Sedano R; Hogan M; Nguyen TM; Chang J; Zou GY; Macdonald JK; Vande Casteele N; Hanzel J; Crowley E; Battat R; Dulai PS; Singh S; D'Haens G; Sandborn W; Feagan BG; Ma C; Jairath V
J Crohns Colitis; 2022 Feb; 16(2):224-243. PubMed ID: 34309658
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
Ma C; Guizzetti L; Panaccione R; Fedorak RN; Pai RK; Parker CE; Nguyen TM; Khanna R; Vande Casteele N; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2018 Jun; 47(12):1578-1596. PubMed ID: 29696670
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Solitano V; Vuyyuru SK; MacDonald JK; Zayadi A; Parker CE; Narula N; Peyrin-Biroulet L; Danese S; Feagan BG; Singh S; Ma C; Jairath V
J Crohns Colitis; 2023 Nov; 17(11):1800-1816. PubMed ID: 37317532
[TBL] [Abstract][Full Text] [Related]
17. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
18. Natalizumab for induction of remission in Crohn's disease.
Nelson SM; Nguyen TM; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006097. PubMed ID: 30068022
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease.
Jairath V; Zou G; Parker CE; MacDonald JK; Mosli MH; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Kherad O; Koutsoumpas A; Minas E; Restellini S; Samaan MA; Khanna R; Levesque BG; D'Haens G; Sandborn WJ; Feagan BG
Aliment Pharmacol Ther; 2017 Apr; 45(8):1021-1042. PubMed ID: 28164348
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
